Qatar’s National Expanded Metabolic Newborn Screening Program: Incidence and Outcomes
Tala M. Jamaleddin(Qatar University), Mashael Al‐Shafai(Qatar University), Sara Musa(Hamad Medical Corporation), Hilal Al Rifai(University of London), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Rola Mitri(Hamad Medical Corporation), Mamatha Ramaswamy(Hamad Medical Corporation), Karen El‐Akouri(Hamad Medical Corporation), Noora Shahbeck(Hamad Medical Corporation), Ghassan Abdoh(Hamad Medical Corporation), Sumaya Abiib(Qatar University), Rehab Ali(Hamad Medical Corporation), Osama Y. Al-Dirbashi(United Arab Emirates University)
Cited by 2
Related Papers
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders
|Science|2014|548
Guidelines for the diagnosis and management of cystathionine beta‐synthase deficiency
|Journal of Inherited Metabolic Disease|2016|335